Navigation Links
How mitochondrial gene defects impair respiration, other major life functions
Date:9/24/2009

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Some names of mitochondrial disorders are Leigh's disease, MELAS syndrome and complex I deficiency. These are often severe and progressive conditions that attack brain, muscles and numerous other parts of the body.

Mitochondrial diseases are individually very rare, but because hundreds of them exist, they collectively have a large impact, affecting at least 1 in 5,000 people, and perhaps more, who often remain undiagnosed. In addition to a wide array of diseases originating in the mitochondria itself, malfunctioning mitochondria also contribute to complex disorders like Parkinson's disease, Alzheimer's disease, epilepsy and diabetes, among others.

For such crucial biological actors, much remains unknown about exactly how mitochondria function. A new study, published Aug. 12 in the online journal PLoS One, sheds light on mitochondrial biology.

Using genetic engineering, researchers interrupted the activity of individual genes directly involved in the production of energy within mitochondria. "If we knock down the function of specific system components, what happens?" said study leader Marni J. Falk, M.D., who directs the Mitochondrial-Genetics Disease Clinic at The Children's Hospital of Philadelphia. "Our ultimate goal is to translate the knowledge into targeted therapies, that is, effective ways to intervene. But first we need to understand the underlying disease mechanisms."

Falk's team made use of a simple model organism often studied in biology, Caenorhabditis elegans, which is a small worm called a nematode. Because mitochondria arose very early in evolution and play such
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Large reservoir of mitochondrial DNA mutations identified in humans
2. Mitochondrial cholesterol makes response to chemotherapy difficult in hepatic cancer
3. Hebrew University develops novel approach for treating mitochondrial disorders
4. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
5. Zebrafish to shed light on human mitochondrial diseases
6. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
7. Essential nutrient found in eggs may help lower risk of neural tube defects
8. Embryology study offers clues to birth defects
9. Folic acid to prevent congenital heart defects
10. Low levels of vitamin B12 may increase risk for neural tube defects
11. Case Western Reserve University uncovers genetic basis for some birth defects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Tom Bowman, an expert in communicating scientific issues ... has developed a series of graphics that translate key ... (IPCC) report for public audiences. These new graphics provide ... to make informed decisions about climate change risks and ... means to clearly and accurately communicate findings in the ...
(Date:12/16/2009)... Dec. 2 DigitalPersona, Inc., a ... today announced an agreement with IBM to ... biometric fingerprint technology on IBM SurePOS 500 ... allows point-of-sale applications to more easily and ... can be linked to the individuals who ...
(Date:12/16/2009)... 2009 National Instruments (Nasdaq: ... and control, and DENSO Robotics, a leader ... technology, today announced their collaboration to integrate ... robotic arms. The collaboration increases productivity and ... manufacturing applications. In today,s trend toward high-mix, ...
Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 1Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 3Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 1Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3
... cancer survivors might one day avoid the prospect of ... that would involve using stem cells derived from their ... studying the potential these cells may have for regenerating ... researchers hope to prove that an injection of fat-derived ...
... response to higher global temperatures may be somewhat overstated ... to adjust to changing conditions, according to researchers from ... published April 28 by Science, a team led by ... percent more carbon will be stored in plants and ...
... A jumping gene first identified in a cabbage-eating moth may ... gene therapy, researchers say. , , They compared the ... insert themselves into a cell's DNA and produce a desired ... radiation therapy. , They found the piggyBac transposon was five ...
Other Biology News:Fat stem cells being studied as option for breast reconstruction 2Plants' role in global warming re-examined 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...
(Date:12/15/2009)... Minn., Dec. 15 The Mosaic Company (NYSE: ... fiscal year 2010 earnings results and financial tables on ... on the New York Stock Exchange. Results will ... ,, The Company will host a conference call with ... the results. The call will begin at 11:00 ...
(Date:12/15/2009)... PHILADELPHIA and LONDON, Dec. 15 ... Thomson Pharma ® has become the first ... trial protocol and outcome information. This highly anticipated ... Pharma customers this month. ,, ... trial intelligence from registries, publications, press releases, conferences, ...
(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... BEDMINSTER, N.J., Feb. 29 NPS,Pharmaceuticals, Inc. (Nasdaq: ... executive vice president, chief operating officer, and chief,executive ... Brothers,Eleventh Annual Global Healthcare Conference in Miami on ... presentation will be available as a live,webcast with ...
... Kendle (Nasdaq: KNDL ), a,leading, ... Vice President and Chief Marketing Officer Simon,Higginbotham ... James,Institutional Investors Conference. The conference will be ... Orlando, March 2-5, 2008. Kendle,s,presentation is scheduled ...
... Tests Based on Company,s microRNA ... Technology on Schedule for 2008, REHOVOT, Israel and ... ROSG ), a leading,molecular diagnostics company, today reported a narrower operating ... corresponding,period of 2006, and said it remains solidly on target for ...
Other Biology Technology:Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference 2Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 2Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 3Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 4Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 5Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 6Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 7Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 8Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 9Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 10Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 11Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results 12
One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....
MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2...
SHEEP ANTI DEHYDROEPIANDROSTERONE...
This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...
Biology Products: